A
8.22
-0.03 (-0.30%)
| Previous Close | 8.24 |
| Open | 8.12 |
| Volume | 612,409 |
| Avg. Volume (3M) | 3,327,454 |
| Market Cap | 1,263,379,200 |
| Price / Earnings (Forward) | 303.03 |
| Price / Sales | 1.48 |
| Price / Book | 126.55 |
| 52 Weeks Range | |
| Earnings Date | 30 Jul 2026 |
| Profit Margin | -25.77% |
| Operating Margin (TTM) | -18.74% |
| Diluted EPS (TTM) | -1.14 |
| Quarterly Revenue Growth (YOY) | 22.20% |
| Total Debt/Equity (MRQ) | 6,465.30% |
| Current Ratio (MRQ) | 2.76 |
| Operating Cash Flow (TTM) | -11.25 M |
| Levered Free Cash Flow (TTM) | -24.32 M |
| Return on Assets (TTM) | -9.33% |
| Return on Equity (TTM) | -291.71% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Mixed | Bearish |
| Medical Devices (Global) | Mixed | Bearish | |
| Stock | Alphatec Holdings, Inc. | Bearish | Bullish |
AIStockmoo Score
0.1
| Analyst Consensus | 1.5 |
| Insider Activity | 3.5 |
| Price Volatility | 0.5 |
| Technical Moving Averages | -2.5 |
| Technical Oscillators | -2.5 |
| Average | 0.10 |
|
Alphatec Holdings Inc is a medical technology company focused on the designing, development, and advancement of products for the surgical treatment of spinal disorders associated with disease and degeneration, congenital deformities, and trauma. The company's spine approach technologies include Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion among others. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Small Core |
| % Held by Insiders | 21.42% |
| % Held by Institutions | 63.24% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Tremblant Capital Group | 31 Mar 2026 | 2,192,084 |
| 52 Weeks Range | ||
| Median | 20.00 (143.46%) | |
| Total | 1 Buy | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Stifel | 09 Mar 2026 | 20.00 (143.46%) | Buy | 12.87 |
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| VALENTINE KEITH | 6.99 | - | 35,000 | 244,650 |
| Aggregate Net Quantity | 35,000 | |||
| Aggregate Net Value ($) | 244,650 | |||
| Aggregate Avg. Buy ($) | 6.99 | |||
| Aggregate Avg. Sell ($) | - | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| VALENTINE KEITH | Director | 11 May 2026 | Buy (+) | 35,000 | 6.99 | 244,650 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |